68ga-dotanoc and Gynecomastia

68ga-dotanoc has been researched along with Gynecomastia* in 1 studies

Other Studies

1 other study(ies) available for 68ga-dotanoc and Gynecomastia

ArticleYear
68Ga-DOTANOC PET-CT demonstrating in vivo somatostatin receptor expression in idiopathic gynecomastia.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:8

    Gynecomastia is abnormal enlargement of the male breasts due to the excess growth of glandular component. A 65-year-old man with medullary carcinoma of thyroid underwent (68)Ga-DOTANOC PET-CT for somatostatin receptor (SSTR) scintigraphy. Extensive nodal, bone, and bone marrow disease was seen. Interestingly, increased (68)Ga-DOTANOC uptake was also noted in bilateral enlarged mammary glands (gynecomastia). Although SSTR types 1 and 3 have been identified in the normal female breast, no report exists regarding SSTR expression in gynecomastia.

    Topics: Aged; Gene Expression Regulation, Neoplastic; Gynecomastia; Humans; Male; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Tomography, X-Ray Computed

2013